Old Web
English
Sign In
Acemap
>
authorDetail
>
Lori M. Guillot
Lori M. Guillot
Tulane University
Cancer research
Hsp27
Phosphorylation
MAPK/ERK pathway
Signal transduction
4
Papers
118
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation
2012
Cancer Biology & Therapy
James W. Antoon
Melyssa R. Bratton
Lori M. Guillot
Scott Wadsworth
Virgilio A. Salvo
Matthew E. Burow
Show All
Source
Cite
Save
Citations (7)
Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase.
2012
American Journal of Cancer Research
James W. Antoon
Melyssa R. Bratton
Lori M. Guillot
Scott Wadsworth
Virgilio A. Salvo
Steven Elliott
John A. McLachlan
Matthew E. Burow
Show All
Source
Cite
Save
Citations (15)
Original Article Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase
2012
James W. Antoon
Melyssa R. Bratton
Lori M. Guillot
Scott Wadsworth
Virgilio A. Salvo
Steven Elliott
John A. McLachlan
Matthew E. Burow
Show All
Source
Cite
Save
Citations (0)
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
2010
Breast Cancer Research and Treatment
Lyndsay V. Rhodes
Shannon E. Muir
Steven Elliott
Lori M. Guillot
James W. Antoon
Patrice Penfornis
Syreeta L. Tilghman
Virgilio A. Salvo
Juan P. Fonseca
Michelle Lacey
Barbara S. Beckman
John A. McLachlan
Brian G. Rowan
Radhika Pochampally
Matthew E. Burow
Show All
Source
Cite
Save
Citations (96)
1